norstella-logo-white
News

Norstella completes acquisition of Citeline to form $5B pharma intelligence group

Although financial terms weren’t disclosed, Norstella estimates that it is now a $5 billion player in the market, the company said in a Nov. 1 press release. The acquisition was first announced in June.

Citeline, which was formerly known as Pharma Intelligence, joins Norstella’s other four constituent groups: pharma commercial intelligence provider Evaluate, market access specialist MMIT, healthcare data analytics software provider Panalgo and market access consultancy The Dedham Group.

Read More